Disclosure: Bear in mind that some of the links in this post are affiliate links, and if you go through them to make a purchase, I will earn a commission. Keep in mind that I link these companies and their products because of their quality and not because of the commission I receive from your purchases. The decision is yours, and whether or not you decide to buy something is completely up to you.
Hey folks, Jenna Lofton here. Today I’m sharing my full Skousen Report review, Dr. Mark Skousen’s flagship investment newsletter from The Oxford Club.
If you read my original review, you know the backstory here. Skousen’s sales pitch a few months ago was built around a specific SpaceX IPO prediction, complete with a countdown timer and a date attached. I went in skeptical. That date came and went without an announcement, which was exactly the kind of thing that makes me roll my eyes at newsletter marketing.
Then SpaceX actually filed its S-1, actually went public, and actually listed on Nasdaq under ticker SPCX, close enough to Skousen’s original window that the man earned back a fair amount of credibility with me.
Now there’s a new pitch. This one is called “Elon’s Hit List,” a report naming three publicly traded companies Skousen believes Elon Musk is preparing to acquire before a January 1, 2027 deadline tied to Pentagon contract requirements. I updated this review to cover the new campaign, what’s actually inside the current offer, and whether the pricing and guarantee still make this worth your time.
Short version: Skousen’s SpaceX IPO thesis played out. That’s the single biggest reason to take his current “Elon’s Hit List” pitch seriously instead of dismissing it as more countdown-timer marketing.
The new report names three companies Skousen believes are acquisition targets, an AI compute company, a rare mineral rights holder, and a satellite communications competitor, plus the specific return percentages (300%, 500% and higher) are his projections, not guarantees. Treat them accordingly.
At $59-$129 with a 365-day guarantee, the newsletter itself remains one of the more credentialed, disciplined services I’ve reviewed. The acquisition speculation is the riskier part of the pitch; the underlying macro research is the reason to actually subscribe.